Becherer Babette E, Heeg Erik, Young-Afat Danny A, Vrancken Peeters Marie-Jeanne T F D, Rakhorst Hinne A, Mureau Marc A M
From the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam.
Dutch Institute for Clinical Auditing.
Plast Reconstr Surg. 2023 Apr 1;151(4):693-702. doi: 10.1097/PRS.0000000000009979. Epub 2022 Dec 5.
In immediate implant-based breast reconstruction (IBBR), large variation is observed in current practices between a direct-to-implant and a two-stage approach (insertion of a breast implant after a tissue expander). This population-based study aimed to compare unplanned short- and long-term revision incidence between direct-to-implant and two-stage IBBR in The Netherlands.
All patients who underwent immediate IBBR following a mastectomy between 2015 and 2019 were selected from the nationwide Dutch Breast Implant Registry. Short- and long-term unplanned revision incidences were studied per immediate IBBR, including revision indications and the total number of additional operations. Confounding by indication was limited using propensity score matching.
A total of 4512 breast implants (3948 women) were included, of which 2100 (47%) were for direct-to-implant IBBR and 2412 (53%) were for two-stage IBBR. Median (IQR) follow-up was 29 months (range, 16 to 45 months) and 33 months (range, 21 to 47 months), respectively. Short-term revision incidence was 4.0% and 11.7%, respectively (conditional OR, 0.31; 95% CI, 0.23 to 0.42%). Long-term revision incidence was 10.6% (95% CI, 9.2 to 12.1%) and 16.4% (95% CI, 14.8 to 17.9%), respectively. In the propensity score-matched cohort, similar results were found. In the direct-to-implant group, more breasts were reconstructed within the planned number of operations than in the two-stage group.
Unplanned revision surgery occurred less often after direct-to-implant IBBR, and more breasts were reconstructed within the planned number of operations compared to two-stage IBBR. These results, based on real-world data, are important for improving patient counseling and shared decision-making.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.
在即刻植入式乳房重建(IBBR)中,直接植入式和两阶段法(在组织扩张器后植入乳房植入物)的当前实践存在很大差异。这项基于人群的研究旨在比较荷兰直接植入式和两阶段IBBR的计划外短期和长期翻修发生率。
从全国性的荷兰乳房植入物登记处选取2015年至2019年间接受乳房切除术后即刻进行IBBR的所有患者。对每个即刻IBBR研究短期和长期计划外翻修发生率,包括翻修指征和额外手术的总数。使用倾向评分匹配来限制指征混杂。
共纳入4512个乳房植入物(3948名女性),其中2100个(47%)用于直接植入式IBBR,2412个(53%)用于两阶段IBBR。中位(IQR)随访时间分别为29个月(范围16至45个月)和33个月(范围21至47个月)。短期翻修发生率分别为4.0%和11.7%(条件OR,0.31;95%CI,0.23至0.42%)。长期翻修发生率分别为10.6%(95%CI,9.2至12.1%)和16.4%(95%CI,14.8至17.9%)。在倾向评分匹配队列中,发现了类似结果。在直接植入式组中,与两阶段组相比,更多乳房在计划手术次数内完成重建。
直接植入式IBBR后计划外翻修手术的发生率较低,与两阶段IBBR相比,更多乳房在计划手术次数内完成重建。这些基于真实世界数据的结果对于改善患者咨询和共同决策很重要。
临床问题/证据水平:风险,II级。